Double trouble for CML
- PMID: 28381535
- DOI: 10.1126/scitranslmed.aan2773
Double trouble for CML
Abstract
Combining two BCR-ABL1 inhibitors with nonoverlapping mechanisms of action eradicates CML and prevents recurrence.
Copyright © 2017, American Association for the Advancement of Science.
Comment on
-
The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1.Nature. 2017 Mar 30;543(7647):733-737. doi: 10.1038/nature21702. Epub 2017 Mar 22. Nature. 2017. PMID: 28329763
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
